Furthermore, FASN expression was significantly increased in metastatic melanomas when compared to non‐metastatic melanomas (p = 0.006); but no significant difference was noted between primary tumor and lymph node metastasis (Figure 4G) (p = 1.00). Here, FASN is linked to metastatic malignant neoplasm in the lymph nodes.